business

Cross Keys Capital Advises Solinsky EyeCare in ReFocus Deal

Summarized from GlobalNewswire

Cross Keys Capital served as exclusive financial adviser to Solinsky EyeCare as the practice partnered with ReFocus Eye Health.

Cross Keys Capital announced Monday that it served as the exclusive financial adviser to Solinsky EyeCare in a newly completed partnership with ReFocus Eye Health, marking another consolidation move in the competitive eye care sector.

The deal brings Solinsky EyeCare into ReFocus Eye Health's growing network of ophthalmology and optometry practices, a model that has gained significant traction as private equity-backed platforms pursue regional eye care providers across the United States.

Read more OKX, MetaMask, Matter Labs Back AI Agent Dispute Court →

Cross Keys Capital, an investment bank specializing in lower middle-market healthcare transactions, played a central advisory role in structuring and negotiating the partnership on behalf of Solinsky EyeCare, helping the practice navigate the complexities of aligning with a larger platform organization.

Partnerships like this one reflect a broader industry trend in which independent eye care practices seek scale, operational support, and capital access through affiliation with larger platforms, while retaining clinical autonomy. ReFocus Eye Health has been an active acquirer in this space, building out a multisite presence across multiple states.

Financial terms of the Solinsky EyeCare and ReFocus Eye Health partnership were not disclosed. Continue reading at GlobalNewswire.

Frequently Asked Questions

Q.Who advised Solinsky EyeCare in its partnership with ReFocus Eye Health?

Cross Keys Capital served as the exclusive financial adviser to Solinsky EyeCare in the transaction.

Q.What is ReFocus Eye Health?

ReFocus Eye Health is a platform organization that partners with ophthalmology and optometry practices, building a multisite network across the United States.

Q.What were the financial terms of the Solinsky EyeCare and ReFocus Eye Health deal?

The financial terms of the partnership were not disclosed in the announcement.

More in business →